Validation of a Scoring System for Predicting Malignancy in Patients Diagnosed with Atypical Ductal Hyperplasia Using an Ultrasound-Guided Core Needle Biopsy

다국어 초록 (Multilingual Abstract)

Purpose: The need for surgical excision in patients with ultrasound-guided core needle biopsy (CNB)-diagnosed atypical ductal hyperplasia (ADH) remains an issue of debate. The present study sought to validate a scoring system (the U score, for underestimation) that we have previously developed for predicting malignancy in CNB-diagnosed ADH. Methods: The study prospectively enrolled 85 female patients with CNB-diagnosed ADH who underwent subsequent surgical excision. Underestimation was defined as a surgical specimen having malignant foci. Results: The overall underestimation rate was 37% (31/85). Multivariate analysis showed that a clinically palpable mass, microcalcification on imaging, size >15 mm and a patient age of ≥50 years were independently associated with underestimation. When applied to the scoring system, the validation score was significant (p<0.001; area under the curve, 0.852). No patient with a U score <3.5 had an underestimated lesion. Conclusion: The present study successfully validated the efficacy of our scoring system for predicting malignancy in CNB-diagnosed ADH. A U score of ≤3.5 indicates that surgical excision may not be necessary.

참고문헌 (Reference)

1 Ancona A, "Vacuum-assisted biopsy diagnosis of atypical ductal hyperplasia and patient management" 116 : 276-291, 2011

2 Jang M, "Underestimation of Atypical Ductal Hyperplasia at Sonographically Guided Core Biopsy of the Breast" American Roentgen Ray Society 191 : 1347-1351, 200811

3 박해린, "The Current Role of Vacuum Assisted Breast Biopsy System in Breast Disease" 한국유방암학회 14 (14): 1-7, 2011

4 Nariya Cho, "Sonographically Guided Core Biopsy of the Breast: Comparison of 14-Gauge Automated Gun and 11-Gauge Directional Vacuum-Assisted Biopsy Methods" 대한영상의학회 6 (6): 102-109, 2005

5 Lee JW, "Sonographic lesion size of ductal carcinoma in situ as a preoperative predictor for the presence of an invasive focus" 98 : 15-20, 2008

6 이은숙, "Scoring system for predicting malignancy in patients diagnosed with atypical ductal hyperplasia at ultrasound-guided core needle biopsy" 112 : 189-195, 200806

7 Chae BJ, "Predictive factors for breast cancer in patients diagnosed atypical ductal hyperplasia at core needle biopsy." 7 : 77-, 2009

8 Linda A, "Nonsurgical management of high-risk lesions diagnosed at core needle biopsy: can malignancy be ruled out safely with breast MRI?" 198 : 272-280, 2012

9 Forgeard C, "Is surgical biopsy mandatory in case of atypical ductal hyperplasia on 11-gauge core needle biopsy? A retrospective study of 300 patients" 196 : 339-345, 2008

10 Ingegnoli A, "Flat epithelial atypia and atypical ductal hyperplasia: carcinoma underestimation rate" 16 : 55-59, 2010

11 정우희, "Factors in the Breast Core Needle Biopsies of Atypical Ductal Hyperplasia that Can Predict Carcinoma in the Subsequent Surgical Excision Specimens" 한국유방암학회 13 (13): 132-137, 2010

12 Wagoner MJ, "Extent and histologic pattern of atypical ductal hyperplasia present on core needle biopsy specimens of the breast can predict ductal carcinoma in situ in subsequent excision" 131 : 112-121, 2009

13 Hoang JK, "Can mammographic findings help discriminate between atypical ductal hyperplasia and ductal carcinoma in situ after needle core biopsy?" 17 : 282-288, 2008

14 Masood S, "Borderline breast lesions: diagnostic challenges and clinical implications" 18 : 190-198, 2011

15 Londero V, "Borderline breast lesions: comparison of malignancy underestimation rates with 14-gauge core needle biopsy versus 11-gauge vacuum-assisted device" 21 : 1200-1206, 2011

16 McGhan LJ, "Atypical ductal hyperplasia on core biopsy: an automatic trigger for excisional biopsy?" 19 : 3264-3269, 2012

17 Sneige N, "Atypical ductal hyperplasia diagnosis by directional vacuum-assisted stereotactic biopsy of breast microcalcifications. Considerations for surgical excision" 119 : 248-253, 2003